D-0153-2017 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-0153-2017 was initiated by Hospira Inc. on Nov 1, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Complaints of broken tips on the ampules. The recall status is terminated (terminated Aug 28, 2018). Affected quantity: 797,800 ampules.

Recall details

Product Type
Drugs
Report Date
Nov 30, 2016
Initiation Date
Nov 1, 2016
Termination Date
Aug 28, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
797,800 ampules

Product description

Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32

Reason for recall

Lack of Assurance of Sterility: Complaints of broken tips on the ampules.

Distribution pattern

Nationwide

Code information

Lot #5 9277EV, 60028EV, 6008EV, Exp 11/1/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0153-2017
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0153-2017. Report a data issue: hello@regdatalab.com.